European Leukemia Trial Registry
Trial: 04-30 (INSPIRE)

More Details
Title Internationale, randomisierte, kontrollierte Phase-III-Studie mit Rigosertib im Vergleich zur Behandlung gemäß Entscheidung des Prüfarztes bei Patienten mit myelodysplastischem Syndrom nach Versagen einer hypomethylierenden Substanz
Scientific Title Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent
Short Title 04-30 (INSPIRE)
Trialgroup NN
Type of Trial multicentric, randomized, prospective, open-label, double-group
Disease Myelodysplastic Syndrome(MDS) RAEB I
Myelodysplastic Syndrome(MDS) RAEB II
Age -
Status Active
Start of Recruitment 03.12.2015
Leader Platzbecker, Prof. Dr. med., Uwe
Contactperson

Study assistance
Rülker, Yvonne
Tel: +49 (0)351 458-19463
Fax: +49 (0)351 458-5893
Email: yvonne.ruelker@uniklinikum-dresden

Centre of Trial Universitätsklinikum Carl Gustav Carus, Dresden
Shortprotocol Shortprotocol
created 10.10.2016 Eva-Maria Ableidinger
changed 29.07.2020 Student Studienregister
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org